NuGen Medical Devices Inc.
NGMD.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -27.46% | 61.01% | 13.20% | -47.10% | -140.28% |
| Total Depreciation and Amortization | -14.35% | -12.18% | -4.48% | -19.45% | 0.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 171.34% | -55.84% | -60.73% | 61.23% | -68.56% |
| Change in Net Operating Assets | 16.98% | 132.11% | 139.98% | -49.39% | 253.75% |
| Cash from Operations | 3.45% | 91.60% | 60.16% | -669.90% | -157.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 99.20% | -- | -- | -- | -- |
| Cash from Investing | 99.20% | -- | -- | -- | -4,562.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 99.15% | 34.80% | 131.75% | 41.79% |
| Issuance of Common Stock | -95.19% | -100.00% | -68.08% | -68.00% | 146.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 650.18% | -100.20% | -68.43% | -46.73% | 159.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 194.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,142.11% | -126.91% | -121.70% | -1,848.12% | 270.70% |